Understanding Liquid Biopsy in Cancer Diagnosis
Home » Understanding Liquid Biopsy in Cancer Diagnosis

GH AMEA on Social Media Understanding Liquid Biopsy in Cancer Diagnosis
Understanding Liquid Biopsy in Cancer Diagnosis
Understanding Liquid Biopsy in Cancer Diagnosis
GH AMEA

The Guardant360® test was recently mentioned in The Straits Times in a news article written by Prof. Yew Oo Tan, a well-known medical oncologist from Icon Cancer Centre, FARRER PARK HOSPITAL, Singapore. In this article, Prof. Tan highlights the advantages of using liquid biopsies like the Guardant360 test in clinical practice and how it can help advanced cancer patients get the right treatment in a quick turnaround time of 7 days upon sample receipt in the laboratory. Read the full article in the news source provided below. Source: The Straits Times © Singapore Press Holdings Limited. Permission required for reproduction.

Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at @guardantamea.com or contact us on WhatsApp: +65 8940 0360.

Guardant360®. Test. Take Action.

Open chat
Message us